Who Paid My Doc
Stacy Scofield-Kaplan
Ophthalmic Plastic and Reconstructive Surgery Naperville, IL Medical Doctor
NPI 1841633989 CMS profile 1397338
636 Raymond Dr Ste 300, Naperville, IL 60563
General payments
$803
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Stacy Scofield-Kaplan of Naperville, IL is reported in the CMS Open Payments database as having received $803 across 35 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 36th percentile of Ophthalmic Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $21 | 1 | |
| 2023 | General | $118 | 1 | |
| 2022 | General | $266 | 12 | |
| 2021 | General | $312 | 16 | |
| 2020 | General | $87 | 5 |
Beside peers
- Stacy Scofield-Kaplan
- Ophthalmic Plastic and Reconstructive Surgery median
- Middle half of Ophthalmic Plastic and Reconstructive Surgery
- National median
In program year 2025, general payments to Stacy Scofield-Kaplan were reported at $21. Among 325 Ophthalmic Plastic and Reconstructive Surgery profiles paid that year, the median was $298 and the middle half received between $132 and $820.
Show as a table
| Year | Stacy Scofield-Kaplan | Ophthalmic Plastic and Reconstructive Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $182 | $73–$467 | $163 |
| 2020 | $87 | $125 | $41–$412 | $114 |
| 2021 | $312 | $173 | $52–$538 | $132 |
| 2022 | $266 | $237 | $78–$809 | $149 |
| 2023 | $118 | $291 | $103–$776 | $160 |
| 2024 | $0 | $304 | $108–$822 | $164 |
| 2025 | $21 | $298 | $132–$820 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 8 drugsPart D claims
492
Drug cost
$30,423
Branded share of claims
83.1%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Xiidra Lifitegrast | Brand | 15 | $10,033 | |
| Restasis Cyclosporine | Brand | 13 | $8,137 | |
| Restasis Multidose Cyclosporine | Brand | 14 | $8,029 | |
| Erythromycin Erythromycin Base | Brand | 229 | $2,278 | |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | Brand | 138 | $1,509 | |
| Doxycycline Hyclate | Generic | 26 | $273 | |
| Ofloxacin | Generic | 11 | $104 | |
| Tramadol Hcl | Generic | 46 | $60 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,260 Part D prescribers listed as Ophthalmology; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 48 billing codesPaid by Medicare
$103,157
Medicare patients
355
Services billed
1,418
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 68% | |
| Arthritis | 43% | |
| Diabetes | 32% | |
| Ischemic heart disease | 26% | |
| Depression | 19% | |
| Chronic kidney disease | 18% | |
| Cancer | 18% | |
| Osteoporosis | 18% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
35 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Ophthalmic Plastic and Reconstructive Surgery in Illinois
Tamara Fountain
Ophthalmic Plastic and Reconstructive Surgery · Deerfield, IL
Paul Phelps
Ophthalmic Plastic and Reconstructive Surgery · Chicago, IL
Kenya Williams
Ophthalmic Plastic and Reconstructive Surgery · Chicago, IL
Liza Cohen
Ophthalmic Plastic and Reconstructive Surgery · Chicago, IL
Krishna Patel
Ophthalmic Plastic and Reconstructive Surgery · Wheaton, IL
Stephen Winkler
Ophthalmic Plastic and Reconstructive Surgery · Des Plaines, IL
Related records
Ophthalmic Plastic and Reconstructive Surgery in Illinois
Practitioners in the same specialty and state, ranked by reported value.
All Ophthalmic Plastic and Reconstructive Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Illinois
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.